SCHEMBL13248253

SCHEMBL13248253

C=C(C)[C@H]1Cc2c(ccc(C3=NOC4COc5cc(OC)c(OC)cc5C34)c2OCC(=O)NCCOCCO)O1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 9/20 0.51
▸ MAPT P10636 8/20 0.51
▸ SMN1; SMN2 Q16637 6/20 0.51
▸ ALDH1A1 P00352 4/20 0.51
▸ CYP2C19 P33261 4/20 0.51
▸ KDM4E B2RXH2 4/20 0.51
▸ LMNA P02545 4/20 0.51
▸ TP53 P04637 4/20 0.51
▸ CYP2C9 P11712 3/20 0.51
▸ TSHR P16473 3/20 0.51
▸ MAPK1 P28482 3/20 0.51
▸ MT-ND4 P03905 3/20 0.51
▸ TDP1 Q9NUW8 3/20 0.51
▸ USP2 O75604 3/20 0.51
▸ NPC1 O15118 2/20 0.51
▸ RAB9A P51151 2/20 0.51
▸ CYP1A2 P05177 2/20 0.51
▸ HPGD P15428 2/20 0.51
▸ GMNN O75496 1/20 0.51
▸ ABCB11 O95342 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13248250 0.94 CYP3A4 (0.50) CYP3A4MAPTSMN1; SMN2ALDH1A1CYP2C19
SCHEMBL13248252 0.94 CYP3A4 (0.49) CYP3A4MAPTSMN1; SMN2ALDH1A1CYP2C19
SCHEMBL13248254 0.92 CYP3A4 (0.48) CYP3A4MAPTSMN1; SMN2ALDH1A1CYP2C19
SCHEMBL13248243 0.91 CYP3A4 (0.52) CYP3A4MAPTSMN1; SMN2ALDH1A1CYP2C19
SCHEMBL19828217 0.91 CYP3A4 (0.54) CYP3A4MAPTSMN1; SMN2ALDH1A1CYP2C19
SCHEMBL15744050 0.90 CYP3A4 (0.53) CYP3A4MAPTSMN1; SMN2ALDH1A1CYP2C19
SCHEMBL13248251 0.89 CYP3A4 (0.47) CYP3A4MAPTSMN1; SMN2ALDH1A1CYP2C19
SCHEMBL13248246 0.89 CYP3A4 (0.47) CYP3A4MAPTSMN1; SMN2ALDH1A1CYP2C19
SCHEMBL10133744 0.88 CYP3A4 (0.59) CYP3A4MAPTSMN1; SMN2ALDH1A1CYP2C19
SCHEMBL2631491 0.87 CYP3A4 (0.58) CYP3A4MAPTSMN1; SMN2ALDH1A1CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8846320-B2 Haptens, hapten conjugates, compositions thereof and method for their preparation and use VENTANA MEDICAL SYSTEMS, INC. (US) 2014-09-30 — — US disclosed
US-20100184087-A1 Haptens, hapten conjugates, compositions thereof and method for their preparation and use VENTANA MEDICAL SYSTEMS, INC. 2010-07-22 — — US disclosed
US-7695929-B2 Derivatives containing oxazole, pyrazole, thiazole, nitroaryl compound, benzofurazan, triterpene, urea, thiourea, rotenoid, coumarin or cyclolignan such as 4-(2-hydroxyphenyl)-1H-benzo[b][1,4]diazepine-2(3H)-one; multiplexed diagnostic assay for multiple targets in sample; antibodies; kits VENTANA MEDICAL SYSTEMS, INC. (US) 2010-04-13 — — US disclosed
Send feedback